California firms launch trials of COVID shot they hope will protect against South African variant

rthfnfvn February 23, 2021
The firms' candidate, called hAd5 T-cell, targets two parts of the novel coronaviirus: the spike protein, more prone to mutations and the nucleocapsid protein, which is less prone.

from U.S. Home | Mail Online https://ift.tt/3utvQZB

Post a Comment

0 Comments

Emoji
(y)
:)
:(
hihi
:-)
:D
=D
:-d
;(
;-(
@-)
:P
:o
:>)
(o)
:p
(p)
:-s
(m)
8-)
:-t
:-b
b-(
:-#
=p~
x-)
(k)